{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:47:52Z","timestamp":1767847672927,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":1129,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI027763"],"award-info":[{"award-number":["P30 AI027763"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","award":["Program for Breakthrough Biomedical Research"],"award-info":[{"award-number":["Program for Breakthrough Biomedical Research"]}],"id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1074\/jbc.m116.751644","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T00:47:41Z","timestamp":1496796461000},"page":"13284-13295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps"],"prefix":"10.1016","volume":"292","author":[{"given":"Kristin M.","family":"Keck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A.","family":"Moquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha G.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica J.","family":"Somberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie M.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delsy M.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JJ L.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M116.751644_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrd703","article-title":"Strategies in the design of antiviral drugs","volume":"1","author":"De Clercq","year":"2002","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.M116.751644_bib2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/0003-4819-154-11-201106070-00345","article-title":"Thirty years of HIV and AIDS: future challenges and opportunities","volume":"154","author":"Dieffenbach","year":"2011","journal-title":"Ann. Intern. Med"},{"key":"10.1074\/jbc.M116.751644_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.M116.751644_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M116.751644_bib5","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"Reactivation and lytic replication of EBV","author":"Kenney","year":"2007"},{"key":"10.1074\/jbc.M116.751644_bib6","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1073\/pnas.82.12.4085","article-title":"Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA","volume":"82","author":"Countryman","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.751644_bib7","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M116.751644_bib8","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","article-title":"Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model","volume":"79","author":"Hong","year":"2005","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M116.751644_bib9","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/JVI.79.8.4806-4818.2005","article-title":"The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4","volume":"79","author":"Baxter","year":"2005","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M116.751644_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0092-8674(04)00402-7","article-title":"Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes","volume":"117","author":"You","year":"2004","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.751644_bib11","doi-asserted-by":"crossref","first-page":"8909","DOI":"10.1128\/JVI.00502-06","article-title":"Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes","volume":"80","author":"You","year":"2006","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M116.751644_bib12","doi-asserted-by":"crossref","first-page":"12009","DOI":"10.1128\/JVI.01680-08","article-title":"The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4","volume":"82","author":"Lin","year":"2008","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M116.751644_bib13","doi-asserted-by":"crossref","first-page":"e1002334","DOI":"10.1371\/journal.ppat.1002334","article-title":"RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus","volume":"7","author":"Palermo","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.M116.751644_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1189\/jlb.0312165","article-title":"BET bromodomain inhibition as a novel strategy for reactivation of HIV-1","volume":"92","author":"Banerjee","year":"2012","journal-title":"J. Leukoc. Biol"},{"key":"10.1074\/jbc.M116.751644_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4161\/cc.23309","article-title":"BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism","volume":"12","author":"Boehm","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.M116.751644_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/nar\/gks976","article-title":"The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation","volume":"41","author":"Li","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.M116.751644_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.celrep.2012.09.008","article-title":"Reactivation of latent HIV-1 by inhibition of BRD4","volume":"2","author":"Zhu","year":"2012","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.M116.751644_bib18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.751644_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.751644_bib20","doi-asserted-by":"crossref","first-page":"19754","DOI":"10.1073\/pnas.1310658110","article-title":"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain","volume":"110","author":"Picaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.751644_bib21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/276270a0","article-title":"Activation of latent Epstein-Barr virus by antibody to human IgM","volume":"276","author":"Tovey","year":"1978","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.751644_bib22","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas","volume":"78","author":"Feng","year":"2004","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M116.751644_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbrc.2016.04.070","article-title":"Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels","volume":"474","author":"Phan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M116.751644_bib24","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3109\/10428194.2015.1079317","article-title":"Bendamustine reactivates latent Epstein-Barr virus","volume":"57","author":"Fernandez","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1074\/jbc.M116.751644_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0092-8674(88)90028-1","article-title":"Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus","volume":"55","author":"Hammerschmidt","year":"1988","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.751644_bib26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ng.154","article-title":"Combinatorial patterns of histone acetylations and methylations in the human genome","volume":"40","author":"Wang","year":"2008","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M116.751644_bib27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","article-title":"Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma","volume":"24","author":"Chapuy","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M116.751644_bib28","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1093\/nar\/gkv212","article-title":"Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression","volume":"43","author":"Ramasubramanyan","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.M116.751644_bib29","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1128\/jvi.66.8.5030-5039.1992","article-title":"Trans-acting requirements for replication of Epstein-Barr virus ori-Lyt","volume":"66","author":"Fixman","year":"1992","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M116.751644_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s13365-016-0435-6","article-title":"The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC","volume":"22","author":"Wollebo","year":"2016","journal-title":"J. Neurovirol"},{"key":"10.1074\/jbc.M116.751644_bib31","doi-asserted-by":"crossref","first-page":"e1005950","DOI":"10.1371\/journal.ppat.1005950","article-title":"An epigenetic compound library screen identifies BET inhibitors that promote HSV-1 and -2 replication by bridging P-TEFb to viral gene promoters through BRD4","volume":"12","author":"Ren","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.M116.751644_bib32","doi-asserted-by":"crossref","first-page":"507.e5","DOI":"10.1016\/j.chom.2017.03.007","article-title":"Transcriptional elongation of HSV immediate early genes by the super elongation complex drives lytic infection and reactivation from latency","volume":"21","author":"Alfonso-Dunn","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1074\/jbc.M116.751644_bib33","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1038\/onc.2013.242","article-title":"Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors","volume":"33","author":"Tolani","year":"2014","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M116.751644_bib34","doi-asserted-by":"crossref","first-page":"e1006100","DOI":"10.1371\/journal.ppat.1006100","article-title":"BET-inhibitors disrupt Rad21-dependent conformational control of KSHV latency","volume":"13","author":"Chen","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.M116.751644_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.chembiol.2016.03.010","article-title":"GNF-2 inhibits dengue virus by targeting Abl kinases and the viral E protein","volume":"23","author":"Clark","year":"2016","journal-title":"Cell Chem. Biol"},{"key":"10.1074\/jbc.M116.751644_bib36","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1128\/JVI.01671-13","article-title":"Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells","volume":"87","author":"Sun","year":"2013","journal-title":"J. Virol"},{"key":"10.1074\/jbc.M116.751644_bib37","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1099\/0022-1317-71-7-1481","article-title":"Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line","volume":"71","author":"Gregory","year":"1990","journal-title":"J. Gen. Virol"},{"key":"10.1074\/jbc.M116.751644_bib38","first-page":"1499","article-title":"Lentivirus production","author":"Wang","year":"2009","journal-title":"J. Vis. Exp"},{"key":"10.1074\/jbc.M116.751644_bib39","first-page":"11.13.1","article-title":"RNA-seq data: challenges in and recommendations for experimental design and analysis","volume":"83","author":"Williams","year":"2014","journal-title":"Curr. Protoc. Hum. Genet. Genet"},{"key":"10.1074\/jbc.M116.751644_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb2103s69","article-title":"Chromatin immunoprecipitation for determining the association of proteins with specific genomic sequences in vivo","author":"Aparicio","year":"2005","journal-title":"Curr. Protoc. Mol. Biol"},{"key":"10.1074\/jbc.M116.751644_bib41","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol"},{"key":"10.1074\/jbc.M116.751644_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2011.04.004","article-title":"Occupancy of chromatin organizers in the Epstein-Barr virus genome","volume":"415","author":"Holdorf","year":"2011","journal-title":"Virology"},{"key":"10.1074\/jbc.M116.751644_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.gdata.2017.05.012","article-title":"RNA-seq detects pharmacological inhibition of Epstein-Barr virus late transcription during spontaneous reactivation","volume":"13","author":"Phan","year":"2017","journal-title":"Genom. Data"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820385550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820385550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M116.751644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T09:26:26Z","timestamp":1641288386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820385550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":43,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0021925820385550"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m116.751644","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M116.751644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}